FHIR IG analytics83,935 resources
By Version
By Authority
By Realm
Start Prev Rows 83400 - 83600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|---|
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4162.json | Lab Test Name (Herpes Simplex) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4163.json | Lab Test Name (Histoplasmosis) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4165.json | Lab Test Name (Influenza A virus, H1N1 2009 strain) | active | 2017-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4166.json | Lab Test Name (Jamestown Canyon virus) | active | 2014-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4248.json | Lab Test Name (Lead poisoning) | active | 2016-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4167.json | Lab Test Name (Legionellosis) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4168.json | Lab Test Name (Leptospirosis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4169.json | Lab Test Name (Listeriosis) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4170.json | Lab Test Name (Lyme disease) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4171.json | Lab Test Name (Lymphogranuloma Venereum) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4172.json | Lab Test Name (Malaria) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4174.json | Lab Test Name (Measles) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4175.json | Lab Test Name (Melioidosis) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4176.json | Lab Test Name (Meningococcal Disease) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4249.json | Lab Test Name (Mercury poisoning) | active | 2016-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4178.json | Lab Test Name (MRSA) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4253.json | Lab Test Name (Microorganism) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4177.json | Lab Test Name (Monkeypox Orthopox) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4179.json | Lab Test Name (Mumps) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4243.json | Lab Test Name (Mushroom poisoning) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4254.json | Lab Test Name (Mycobacteria) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4224.json | Lab Test Name (Non-Cholera Vibrio) | active | 2016-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4181.json | Lab Test Name (Nongonococcal Urethritis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4182.json | Lab Test Name (Nontuberculous Mycobacteria) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4183.json | Lab Test Name (Norovirus) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4255.json | Lab Test Name (Parasite) | active | 2015-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4184.json | Lab Test Name (Pertussis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4245.json | Lab Test Name (Pesticide poisoning) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4185.json | Lab Test Name (Plague) | active | 2017-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4186.json | Lab Test Name (Polio) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4187.json | Lab Test Name (Powassan virus) | active | 2014-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4188.json | Lab Test Name (Prion Disease) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4189.json | Lab Test Name (Psittacosis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4190.json | Lab Test Name (Q Fever) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4191.json | Lab Test Name (Rabies) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4192.json | Lab Test Name (Relapsing Fever) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4193.json | Lab Test Name (Respiratory Syncytial Virus) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4242.json | Lab Test Name (Ricin poisoning) | active | 2014-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4194.json | Lab Test Name (Rickettsial infection, other) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4195.json | Lab Test Name (Rift Valley Fever) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4196.json | Lab Test Name (Rotavirus) | active | 2019-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4197.json | Lab Test Name (Rubella) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4199.json | Lab Test Name (SARS) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4198.json | Lab Test Name (Salmonellosis) | active | 2017-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4200.json | Lab Test Name (Shigella) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4201.json | Lab Test Name (Smallpox) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4202.json | Lab Test Name (Spotted fever rickettsiosis) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4207.json | Lab Test Name (St. Louis encephalitis virus) | active | 2015-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4206.json | Lab Test Name (Staphylococcal TSS) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4203.json | Lab Test Name (Staphylococcus aureus) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4204.json | Lab Test Name (Staphylococcus aureus enterotoxin B) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4205.json | Lab Test Name (Staphylococcus aureus food poisoning) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4208.json | Lab Test Name (Streptococcus pneumoniae) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4210.json | Lab Test Name (Streptococcus, group A) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4211.json | Lab Test Name (Streptococcus, group B) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4212.json | Lab Test Name (Syphilis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4213.json | Lab Test Name (Tetanus) | active | 2017-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4214.json | Lab Test Name (Toxoplasmosis) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4215.json | Lab Test Name (Trichinellosis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4216.json | Lab Test Name (Tuberculosis) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4258.json | Lab Test Name (TB Antimicrobial susceptibility test) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4218.json | Lab Test Name (Typhoid Fever) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4219.json | Lab Test Name (Typhus group rickettsiosis) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4220.json | Lab Test Name (Vaccinia) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4221.json | Lab Test Name (Vancomycin resistant Enterococcus) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4222.json | Lab Test Name (Varicella) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4223.json | Lab Test Name (Vesicular Stomatitis) | active | 2016-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4225.json | Lab Test Name (Viral Hemorrhagic Fever) | active | 2015-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4256.json | Lab Test Name (Virus) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4229.json | Lab Test Name (West Nile virus) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4228.json | Lab Test Name (Western equine encephalitis virus) | active | 2011-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4230.json | Lab Test Name (Yellow Fever) | active | 2018-12 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4231.json | Lab Test Name (Yersiniosis) | active | 2017-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7480.json | Lab Test Name (Zika virus) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.4217.json | Lab Test Name (Tularemia) | active | 2018-01 | us | loinc | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.6064.json | Value Type (ELR) | active | 2012-01 | us | tho | |||
| ng.gov.nphcda.immunization | R4 | ValueSet-nigeria-relationship.json | NG-Imm Relationships VS | active | 2026-02 | internal | ||||
| org.dhin-hie.sandbox | R4 | ValueSet-nigeria-relationship.json | NG Relationships VS | active | 2026-02 | internal | ||||
| ihe.iti.mcsd | R4 | ValueSet-MCSDEndpointIdentifierTypeValueSet.json | mCSD Type codes for Endpoint.identifier | active | 2025-10 | uv | ihe | ihe | ||
| ihe.iti.mcsd | R4 | ValueSet-MCSDOrganizationIdentifierTypeValueSet.json | mCSD Type codes for Organization.identifier | active | 2025-10 | uv | ihe | ihe | ||
| ihe.iti.mcsd | R4 | ValueSet-IHE.mCSD.Organization.Location.Types.json | mCSD Types for Organizations and Locations | active | 2025-10 | uv | ihe | ihe | ||
| tw.cathay.fhir.imri | R4 | ValueSet-mcode-cancer-stage-type.json | mCode Cancer Stage Type值集 | active | 2024-04 | tw | internal sct | |||
| tw.cathay.fhir.imri | R4 | ValueSet-mcode-cancer-stage.json | mCode Cancer Stage值集 | active | 2024-04 | tw | internal sct | |||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-margins-after-surgery-eu-i4rc.json | Margins After Surgery | active | 2026-01 | eu | hl7 | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.1370.json | Beta lactam ingredients for allergy determination RXNORM | active | 2024-05 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1078.168.json | medications_COPD | active | 2025-01 | us | hl7 | vsac | ||
| medmij.fhir.nl.r4.imageavailability | R4 | ValueSet-MimetypeXDS-2.16.840.1.113883.2.4.3.11.60.106.11.8--20131212104106.json | Mimetype XDS | draft | nl | oid | ||||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1021.40.json | MDP Test Intensional | active | 2019-01 | us | hl7 | sct | ||
| hl7.fhir.us.ecr | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1034-example.json | Negative or Undetected Lab Result Value | informative | pher | 2025-12 | us | hl7 | sct | |
| de.uk-koeln.nngm.form | R4 | ValueSet-nNGM-MaterialTyp.json | ValueSet - nNGM - MaterialTyp | active | ncit | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-applikationsart.json | MII VS Onkologie Strahlentherapie Applikationsart | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-systemische-therapie-art.json | MII VS Onkologie Systemische Therapie Art | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-ende-grund.json | MII VS Onkologie Strahlentherapie Ende Grund | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-systemische-therapie-ende-grund.json | MII VS Onkologie Systemische Therapie Ende Grund | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-boost.json | MII VS Onkologie Strahlentherapie Boost | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-stellungzurop.json | MII VS Onkologie Strahlentherapie Stellung zur OP | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-systemische-therapie-stellungzurop.json | MII VS Onkologie Systemische Therapie Stellung | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-strahlenart.json | MII VS Onkologie Strahlentherapie Strahlenart | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-zielgebiet.json | MII VS Onkologie Strahlentherapie Zielgebiet | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-nebenwirkung-art.json | MII VS Onkologie Nebenwirkung nach CTCAE Art | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-nebenwirkung-ctcae-grad.json | MII VS Onkologie Nebenwirkung nach CTCAE Grad | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-systemische-therapie-protokolle.json | MII VS Onkologie Systemische Therapie Protokolle | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-strahlungseinheit.json | MII VS Onkologie Strahlentherapie Strahlungseinheit | active | de | ucum | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-therapieempfehlung-typ.json | MII VS Onkologie Therapieempfehlung Typ | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-therapieplanung-typ.json | MII VS Onkologie Therapieplanung Typ | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-verlauf-fernmetastasen.json | MII VS Onkologie Verlauf Fernmetastasen | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-verlauf-lymphknoten.json | MII VS Onkologie Verlauf Lymphknoten | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-verlauf-primaertumor.json | MII VS Onkologie Verlauf Primärtumor | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-verlauf-gesamtbeurteilung.json | MII VS Onkologie Verlauf Gesamtbeurteilung | active | de | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-therapieabweichung.json | MII VS Onkologie Therapieabweichung | active | de | |||||
| hl7.terminology | R5 | ValueSet-v3-Parent.json | Parent | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | ValueSet-v3-Grandparent.json | Grandparent | active | 2014-03 | uv | hl7 | tho | ||
| vzvz.fhir.mitz | R4B | policyrule-codes.json | policyrule-codes ValueSet | draft | 2022-10 | nl | tho | |||
| hl7-france-fhir.administrative-2022 | R4 | fr-location-position-room.json | fr-location-position-room | active | 1 | fhir | 2018-11 | |||
| smart.who.int.icvp | R4 | ValueSet-preQualVaccines.json | preQualVaccines | active | 2025-10 | who | internal | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1281.json | Virtual Encounter | active | 2023-11 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.11.1282.json | Virtual Encounter | active | 2023-11 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.101.12.1089.json | Virtual Encounter | active | 2021-02 | us | hl7 | vsac | ||
| ca.on.phsd.r4-alpha | R4 | vs-PHSDContactPointPurpose.json | PHSDContactPointPurpose | active | ||||||
| ch.fhir.ig.ch-lab-order | R4 | ValueSet-ch-lab-order-study-types.json | Laboratory Study Types | active | 2025-12 | ch | hl7 | loinc | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-treatment-completed-as-planned-i4rc.json | Treatment completed as planned | active | 2026-01 | eu | hl7 | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.11.20.9.54.json | Planned Intervention moodCode | active | 2024-06 | us | hl7 | tho | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.1.11.78.json | Observation Interpretation (HL7) | active | 2024-06 | us | hl7 | tho | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.1.11.10267.json | ParticipationFunction | active | 2024-06 | us | hl7 | tho | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.88.12.3221.6.8.json | Severity | active | 2024-06 | us | hl7 | sct | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7103.json | VPD Laboratory Coded Observation | active | 2015-01 | us | sct rx tho oid | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.5026.json | Lab Test Result PHLIP Salmonella | active | 2011-01 | us | sct oid | |||
| hl7.fhir.be.mycarenet | R4 | ValueSet-be-vs-holder-code-1.json | BeVSHolderCode1 | trial-use | 1 | fhir | 2026-02 | be | hl7 | internal |
| hl7.fhir.be.mycarenet | R4 | ValueSet-be-vs-holder-code-2.json | BeVSHolderCode2 | trial-use | 1 | fhir | 2026-02 | be | hl7 | internal |
| hl7.fhir.uv.tools | R5 | ValueSet-select-by-map-filter.json | SelectByMap Filter Codes (VS) | deprecated | 3 | fhir | 2026-02 | uv | hl7 | fhir |
| hl7.fhir.uv.extensions | R5 | ValueSet-select-by-map-filter.json | SelectByMap Filter Codes (VS) | trial-use | 1 | vocab | 2026-01 | uv | hl7 | fhir |
| vzvz.fhir.mitz | R4B | situatiecode.json | situatiecode ValueSet | draft | 2022-10 | nl | ||||
| kl.dk.fhir.term | R4 | ValueSet-KLInterventionsFFB.json | KLYdelserFFB | active | 2025-08 | dk | oid | |||
| kl.dk.fhir.core | R4 | ValueSet-KLInterventionsFFB.json | KLYdelserFFB | active | 2023-06 | dk | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7107.json | VPD Specimen Role | active | 2013-01 | us | tho | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7104.json | VPD Specimen Type | active | 2020-01 | us | sct tho oid | |||
| maccabi.maccabident.medicationrequest.r4 | R4 | ValueSet-status-of-med-req.json | status Of Medication Request | draft | il | fhir | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.821.json | Treatment Completion Status (HL7) | active | 2008-01 | us | tho | |||
| ans.fr.nos | R4 | ValueSet-JDV-J05-SubjectRole-CISIS.json | JDV_J05-SubjectRole-CISIS | active | 2025-01 | fr | national | |||
| hl7.v2.uv.terminology.v291 | R4 | ValueSet-hl7VSgenderHarmonyConcepts.json | Gender Harmony Concepts (2.9.1 - 1.0.0) | active | 2026-01 | hl7 | tho | |||
| who.ddcc | R4 | ValueSet-VaccineCovid19Icd11ValueSet.json | Vaccine - COVID-19 - Icd11 | draft | 2026-01 | uv | who | icd | ||
| hl7.v2.uv.terminology.v251 | R4 | ValueSet-noOIDfound.json | Specimen Role (2.5.1 - 1.1.0) | active | 2026-01 | hl7 | tho | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.1344.json | Tests for Neisseria gonorrhoeae of unspecified site reported by presence | active | 2024-05 | us | hl7 | loinc | ||
| hl7-france-fhir.administrative-2022 | R4 | fr-insee-code.json | fr-insee-code | draft | 2019-12 | |||||
| hl7.fhir.fr.core | R4 | ValueSet-fr-core-vs-insee-code.json | FR Core ValueSet INSEE code | active | 2026-02 | fr | hl7 | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.4.json | DIRSectionTypeCodes LOINC | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.8.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.15.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.13.json | Homelessness Diagnosis | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.11.json | Transportation Insecurity Diagnosis | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.14.json | Housing Instability Diagnosis | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.9.json | Utility Insecurity Diagnosis | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.12.json | Food Insecurity Diagnosis | active | 2024-01 | us | hl7 | icd | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7110.json | VPD Specimen Reject Reason | active | 2013-01 | us | sct tho | |||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-type-of-biopsy-eu-i4rc.json | Type of Biopsy | active | 2026-01 | eu | hl7 | |||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-type-of-diagnosis-eu-i4rc.json | Type of Diagnosis | active | 2026-01 | eu | hl7 | tho | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-type-of-surgical-approach-eu-i4rc.json | Type of surgical approach | active | 2026-01 | eu | hl7 | internal | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-type-of-systemic-treatment-eu-i4rc.json | Type of Systemic Treatment | active | 2026-01 | eu | hl7 | |||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-type-of-treatment-eu-i4rc.json | Type of Treatment | active | 2026-01 | eu | hl7 | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1021.33.json | Sexual Orientation | active | 2021-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.88.12.80.68.json | Problem Status | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.11.20.9.60.json | Priority Level | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.11.20.9.65.json | Physical Exam Type | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.11.20.9.55.json | Goal Achievement | active | 2024-06 | us | hl7 | sct | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.5027.json | Identifier Type (HL7) (PHLIP for PID3.5) | active | 2011-01 | us | tho | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.5028.json | Method Detail (PHLIP) | active | 2011-01 | us | sct tho | |||
| accdr.fhir.ig.pkg | R4 | vs-Documentv2CompletionStatus.json | Document Status | active | 2023-05 | |||||
| accdr.fhir.ig.pkg | R4 | vs-accdr-v2-observation-status.json | ObservationStatus | active | 2023-05 | tho | ||||
| hl7.fhir.au.base | R4 | ValueSet-au-v3-ActEncounterCode-extended.json | ActEncounterCode - AU Extended | trial-use | 1 | 2026-01 | au | hl7 | tho | |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.5017.json | Resulted Lab Test Name PHLIP Salmonella | active | 2011-01 | us | oid loinc | |||
| ans.fr.terminologies | R4 | ValueSet-jdv-hl7-v3-xActMoodDocumentObservation.json | x_ActMoodDocumentObservation | active | 2025-10 | fr | national | tho | ||
| ans.fr.terminologies | R4 | ValueSet-jdv-hl7-v3-xBasicConfidentialityKind-cisis.json | x_BasicConfidentialityKind | active | 2025-10 | fr | national | tho | ||
| se.electronichealth.fhir.nll.r4 | R4 | access-types.json | Åtkomsttyp | active | 2023-11 | |||||
| se.electronichealth.fhir.nll.r4 | R4 | purpose-types_1.0.1.json | Ändamål | active | 2023-11 | |||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-ExtraordinaryTreatmenCause.json | Ekstra behandling | active | 2022-07 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-AarsagTilProcedureDCCG.json | Årsag til anden/aflastende procedure colorectal cancer | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-HjertestopAarsag.json | Hjertestop Årsag | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-ManglendeEORTC.json | EORTC skema mangler | active | 2022-09 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-ManglendeBehandling.json | Grund til manglende behandling | active | 2022-09 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-BehandlinsplanAendretAarsagDCCG.json | Årsag til ændret behandlingsplan DCCG | active | 2022-09 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-MDTIkkeFulgt.json | MDT-beslutning ikke fulgt; årsag | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-ActilyseIkkeGivet.json | Totaldosis i.v. actilyse er ikke givet; årsag | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-AKFravalgt.json | Fravalg af antikoagulationsbehandling; årsag | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-IkkeBesvaret.json | Ikke besvaret (MDS) | active | 2022-10 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-GenoplivStoppet.json | Genoplivning indstillet - årsag | active | 2022-06 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-AarsagOphoerDNSL.json | Årsag til ophør (DNSL) | active | 2024-01 | internal | ||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-ReoperationAarsagDKRR.json | Reoperation årsager (DKRR) | active | 2022-05 | internal | ||||
| hl7.fhir.cz.terminology | R4 | ValueSet-drzar.json | Drzar (CZ) | trial-use | 2 | 2022-12 | cz | hl7 | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-passport-NS.json | Standard namespaces for passports | draft | 1 | 2023-01 | cz | hl7 | ietf | |
| hl7.fhir.cz.terminology | R4 | ValueSet-healthInsuranceCompanyCode.json | ValueSet of Health Insurance Company Code | trial-use | 2 | 2024-01 | cz | hl7 | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-nclpmat.json | Číselník NCLPMAT | active | 2025-01 | cz | hl7 | |||
| hl7.fhir.cz.terminology | R4 | ValueSet-dlp-formy.json | Lékové formy | trial-use | 2 | 2025-01 | cz | hl7 | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-dlp-lecivepripravky.json | Léčivé přípravky | trial-use | 2 | 2025-01 | cz | hl7 | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-mkn-10.json | Mkn10_5 | active | 2025-12 | cz | hl7 | |||
| hl7.fhir.cz.terminology | R4 | ValueSet-contactrole-cz.json | Contact Role (CZ) | draft | 2025-04 | cz | hl7 | tho | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-lab-document-types.json | Typy laboratorních dokumentů | draft | 2025-11 | cz | hl7 | loinc | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-medical-document-type.json | Typy lékařské dokumentace | draft | 2025-11 | cz | hl7 | loinc | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-nursing-document-type.json | Typ ošetřovatelské dokumentace | draft | 2025-11 | cz | hl7 | loinc | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-cz-coverage-type.json | Číselník typů úhrady | active | 2025-01 | cz | hl7 | tho | ||
| hl7.fhir.cz.terminology | R4 | ValueSet-referralorder-types.json | Typy žádanek | draft | 2025-11 | cz | hl7 | sct loinc |